Brazilian Heart-Prevent Meal - A Pilot Randomized Clinical Trial

Not Applicable

Completed

• Conditions: Cardiovascular Diseases
• Interventions: Other: Brazilian heart-prevent meal; Other: Heart prevent control meal weekly; Other: Heart prevent control Meal monthly

• Registration Number: NCT01453166
• Lead Sponsor: Hospital do Coracao

Brief Summary

The purpose of this study is to evaluate the effectiveness of a brazilian cardioprotective diet plan to reduce cardiovascular risk factors of new cardiovascular events.

Detailed Description

Cardiovascular diseases are the leading cause of mortality in both sexes in Brazil and worldwide. Modifying risk factors such as diet and lifestyle can prevent most cases of cardiovascular disease. This pilot trial is based on specific and traditional brazilian food. The objective is to reduce risk factors such as obesity, high blood pressure,dyslipidemia and diabetes in patients with cardiovascular disease history.

Study Timeline

• Study Start: 2011-09
• Study First Submitted: 2011-10-11
• Study First Submitted QC: 2011-10-13
• Study First Posted: 2011-10-17
• Primary Completion: 2011-12
• Study Completion: 2012-01
• Results First Submitted: 2012-03-15
• Results First Submitted QC: 2012-06-13
• Status Verified: 2012-07
• Last Update Submitted: 2012-07-16
• Results First Posted: 2012-07-17
• Last Update Posted: 2012-07-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 122

Inclusion Criteria

• Any coronary artery disease evidence in the past 10 years; or any ischemic stroke or TIA evidence in the past 10 years; or peripheral arterial disease in the past 10 years; or at least one of the following additional risk factors:
• Diabetes Mellitus; Hypertension; Dyslipidemia; Coronary artery disease family history;
• Asymptomatic carotid artery disease;
• Body mass index> 25 kg/m2 for adults and> 28 kg/m2 for seniors

Exclusion Criteria

• Neurocognitive or psychiatric condition;
• Life expectancy less than 6 months (eg, metastatic malignancy or other defined as clinical trial investigators).
• Pregnancy or breast feeding.
• Hepatic impairment defined as elevated liver enzymes above three times the upper limit of normal
• Renal impairment defined as creatinine values higher than 1.5 mg/dL.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group 1	Brazilian heart-prevent meal	Nutrient profile of the diets used was based on the Brazilian guidelines to cardiovascular disease treatment.The main difference between this group involves a Brazilian version of accessible and energy density concept dietary therapy to cardiovascular diseases. Furthermore, it explores a set of tools and educational materials that help the patient understand and follow the principles of balanced and healthy diet weekly session with the dietitians which could be in person, by phone or in a gourmet shop. During attendances at the gourmet shop, patients received tips for eating in restaurants, instruction on label reading and a list of typical foods. The menus were based on typical foods consumed in Brazil, all foods included in the menu were low-cost and widely available at local markets
Group 2	Heart prevent control meal weekly	Group B received the usual dietary therapy to patients with cardiovascular diseases, which had the same nutrient profile as presented in Group A, but customized by the integration of mediterranean typical foods (e.g. olive oil and nuts). The difference between groups B and C was the number of sessions with the dietician. Group B received weekly sessions, which could be in person or by phone, and group C had monthly in person sessions
Group 3	Heart prevent control Meal monthly	Group C received the usual dietary therapy to patients with cardiovascular diseases, which had the same nutrient profile as presented in Group A and B, but customized by the integration of mediterranean typical foods (e.g. olive oil and nuts) at the same of group B. The difference of group C was the number of sessions with the dietician. That happen monthly in person sessions.

Primary Outcome Measures

Name	Time	Method
Systolic Blood Pressure	12 weeks	Change From Baseline in systolic blood pressure
Total Cholesterol	12 weeks	Change From Baseline in total Cholesterol

Secondary Outcome Measures

Name	Time	Method
Weight	12 weeks	Change From Baseline in weight
Waist Circumference	12 weeks	Change From Baseline in wais circumference
Blood Glucose	12 weeks	Change From Baseline in blood glucose

Trial Locations

Locations (1)

Hospital do Coracao; 🇧🇷 Sao Paulo, Brazil